Skip to main content

Table 3 Metabolic Syndrome criteria and Insulin Resistance

From: Utility of the modified ATP III defined metabolic syndrome and severe obesity as predictors of insulin resistance in overweight children and adolescents: a cross-sectional study

  Age 3–8 Age 9–11 Age 12–19
  Higher IR Higher IR Higher IR
MetS Criterion* Yes No Yes No Yes No
  n = 41 n = 81 n = 54 n = 110 n = 96 n = 194
Waist Circumference % 95 94 (p > .99) 100. 93 (p = .05) 94 82 (p = .01)
Blood Pressure % 66 64 (p > .99) 56 53 (p = .86) 65 56 (p = .21)
Glucose % 7 0 (p = .04) 11 1 (p = .01) 9 1 (p < .01)
Triglycerides % 37 33 (p = .88) 48 46 (p = .96) 41 23 (p < .01)
HDL % 44 37 (p = .59) 48 45 (p = .79) 56 47 (p = .17)
  Age 3–8 Age 9–11 Age 12–19
Number of Components   Higher IR   Higher IR   Higher IR
  n % (n) n % (n) n % (n)
None 3 0 (0) 1 0 (0) 12 8 (1)
Any one 21 29 (6) 32 22 (7) 67 24 (16)
Any two 43 35 (15) 52 35 (18) 88 31 (27)
Any three 40 35 (14) 51 37 (19) 80 35 (28)
Any four 15 40 (6) 26 31 (8) 38 53 (20)
All five 0 - 2 100 (2) 5 80 (4)
  1. * Metabolic syndrome (MetS) by modified ATP III criteria: any 3 or more of waist circumference, blood pressure and triglycerides ≥ 90th percentile, HDL ≤ 40 mg/dL, Glucose ≥ 100 mg/dl. Higher insulin resistance (IR): upper tertile of HOMA. Values presented as %.
  2. % of the number (n) within that age group who had insulin resistance (IR), defined as upper tertile of HOMA.
  3. Test of association (Spearman's rho) of number of categories with higher IR within age group: age 3–8 (p = .34), age 9–11 (p = .18), age 12–19 (p < .01).